Identification of mutations including de novo mutations in Korean patients with hypokalaemic periodic paralysis

Nephrology Dialysis Transplantation

Volumn 16, Issue 5, 2001, Pages 939-944

  Kim, Sung Han ^a   Kim, Un Kyung ^a   Chae, Jae Jin ^a   Kim, Dae Joong ^b,c   Oh, Ha Young ^b   Kim, Byoung Joon ^b   Lee, Chung Choo ^a  

^a Seoul National University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

De novo; Hypokalaemia; Korean; Mutation; Paralysis; Periodic

Indexed keywords

ACETAZOLAMIDE; ARGININE; BIOCHEMICAL MARKER; CALCIUM CHANNEL; CARRIER PROTEIN; DIHYDROPYRIDINE; GLYCINE; HISTIDINE; ION CHANNEL; MICROSATELLITE DNA; SPIRONOLACTONE;

ADULT; ALPHA CHAIN; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CAUCASIAN; CHROMOSOME 1Q; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DIET THERAPY; DISEASE SEVERITY; FAMILY; FAMILY HISTORY; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC LINKAGE; HAPLOTYPE; HUMAN; HUMAN TISSUE; HYPOKALEMIC PERIODIC PARALYSIS; INHERITANCE; KOREA; MALE; PARALYSIS; PENETRANCE; POLYMERASE CHAIN REACTION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RACE; RESTRICTION MAPPING; SCREENING; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0035003905     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.5.939     Document Type: Article

References (19)

1. Kantola IM, Tarssanen LT. Familial hypokalaemic periodic paralysis in Finland. J Neurol Neurosurg Psychiatry 1992; 55: 322-324
2. Talboty J. Periodic paralysis. Medicine 1941; 20: 85-96
3. Lapie P, Lory P, Fontaine B. Hypokalemic periodic paralysis: an autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel. Neuromuscul Disord 1997; 7: 234-240
4. Fontaine B, Vale-Santos J, Jurkat-Rott K et al. Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome lq31-32 in three European families. Nature Genet 1994; 6: 267-272
5. Ptacek LJ, Tawil R, Griggs RC et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 1994; 77: 863-868
6. 1 subunit of the skeletal muscle DHP-sensitive Ca2+ channel (CACNL1A3) to chromosome lq31-q32. Genomics 1993; 15: 107-112
7. Catterall WA. Structure and function of voltage-gated ion channels. Trends Neurosci 1993; 16: 500-506
8. Tanabe T, Takeshima H, Mikami A et al. Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature 1987; 328: 313-318
9. Jurkat-Rott K, Lehmann-Horn F, Elbaz A et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet 1994; 3: 1415-1419
10. Ikeda Y, Watanabe M, Shoji M. [Mutation analysis of the CACNL1A3 gene in Japanese hypokalemic periodic paralysis families]. Nippon Rinsho. Jpn J Clin Med 1997; 55: 3247-3252
11. Elbaz A, Vale-Santos J, Jurkat-Rott K et al. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 Caucasian families. Am J Hum Genet 1995; 56: 374-380
12. Sillen A, Sorensen T, Kantola I, Friis ML, Gustavson KH, Wadelius C. Identification of mutations in the CACNL1A3 gene in 13 families of Scandinavian origin having hypokalemic periodic paralysis and evidence of a founder effect in Danish families. Am J Med Genet 1997; 69: 102-106
13. John SW, Weitzner G, Rozen R, Scriver CR. A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res 1991; 19: 408
14. Grosson CL, Esteban J, McKenna-Yasek D, Gusella JF, Brown RH Jr. Hypokalemic periodic paralysis mutations: confirmation of mutation and analysis of founder effect. Neuromuscul Disord 1996; 6: 27-31
15. Ott J. Strategies for characterizing highly polymorphic markers in human gene mapping. Am J Hum Genet 1992; 51: 283-290
16. Plassart E, Elbaz A, Santos JV et al. Genetic heterogeneity in hypokalemic periodic paralysis (hypoPP). Hum Genet 1994; 94: 551-556
17. Mendell J, Griggs R, Ptacek L. Diseases of muscle. In: Fauci A, Braunwald E, Isselbacher K et al., eds. Harrison's Principles of Internal Medicine, 14 edn, vol. 2. McGraw-Hill, New York, 1998, 2473-2483
18. Cooper DN, Youssoufian H. The CpG dinucleotide and human genetic disease. Hum Genet 1988; 78: 151-155
19. Sommer SS. Recent human germ-line mutation: inferences from patients with hemophilia B. Trends Genet 1995; 11: 141-147